Sterylglucosides (SGs) are composed of a glucose and sterol derivatives, and are distributed in fungi, plants and mammals. We recently identified EGCrP1 and EGCrP2 (endoglycoceramidase-related proteins 1 and 2) as a β-glucocerebrosidase and steryl-β-glucosidase, respectively, in Cryptococcus neoformans. We herein describe an EGCrP2 homologue (Egh1; ORF name, Yir007w) involved in SG catabolism in Saccharomyces cerevisiae. The purified recombinant Egh1 hydrolyzed various β-glucosides including ergosteryl β-glucoside (EG), cholesteryl β-glucoside, sitosteryl β-glucoside, para-nitrophenyl β-glucoside, 4-methylumberifellyl β-glucoside and glucosylceramide. The disruption of EGH1 in S. cerevisiae BY4741 (egh1Δ) resulted in the accumulation of EG and fragmentation of vacuoles. The expression of EGH1 in egh1Δ (revertant) reduced the accumulation of EG, and restored the morphology of vacuoles. The accumulation of EG was not detected in EGH1 and UGT51(ATG26) double-disrupted mutants (ugt51Δegh1Δ), indicating that EG was synthesized by Ugt51(Atg26) and degraded by Egh1 in vivo. These results clearly demonstrated that Egh1 is an ergosteryl-β-glucosidase that is functionally involved in the EG catabolic pathway and vacuole formation in S. cerevisiae.
Introduction
Sterylglucosides (SGs), a class of glycolipid composed of a glucose (Glc) and sterol derivatives, are distributed in bacteria, fungi, plants and mammals (Grille et al. 2010) . The structures of SGs show diversity in the sterol moiety and anomeric linkage of Glc bound to sterols. The main sterol in fungi is ergosterol (Weete et al. 2010) , whereas that in plants and mammals is sitosterol and cholesterol, respectively (Benveniste 2004) . Although most SGs possess β-Glc, the SG of Helicobacter pylori is composed of cholesterol and α-Glc. Helicobacter pylori SG was previously reported to be involved in the suppression of phagocytosis by macrophages (Wunder et al. 2006) . The amount of SG is known to increase under stress conditions, e.g., SG levels in the rat stomach were increased by cold shock (Kunimoto et al. 2003) , while those of slim mold (Murakami-Murofushi et al. 1997) , Pichia pastoris (Sakaki et al. 2001 ) and human fibroblasts (Kunimoto et al. 2000) were increased by heat shock. Although SG has been shown to induce the expression of heat shock protein (HSP) 70 in human fibroblasts (Kunimoto et al. 2002) , the physiological relevance of SGs under stress conditions remains unclear.
Fungal and yeast SGs are synthesized by Ugt51(Atg26), a sterol 3-β-glucosyltransferase (EC 2.4.1.173) (Warnecke et al. 1999) ; however, the in vivo catabolism of SGs has yet to be elucidated because a SG-degrading enzyme had not been identified until the discovery of EGCrP2 (endoglycoceramidase-related protein 2) in Cryptococcus neoformans (Watanabe et al. 2015) . EGCrP2 was detected in C. neoformans as a paralogue of EGCrP1 (endoglycoceramidase-related protein 1) (Ishibashi et al. 2012) , which is a glucocerebrosidase that is capable of degrading glucosylceramide (GlcCer), but not SGs. In contrast to EGCrP1, EGCrP2 hydrolyzed the β-glucosidic linkage in various SGs as well as GlcCer. Furthermore, EGCrP2-disrupted mutants (egcrp2Δ) of C. neoformans were found to accumulate ergosteryl β-glucoside (EG) in vacuoles. These finding clearly indicated that EGCrP2 was the steryl-β-glucosidase that was missing link in the catabolism of EG in C. neoformans.
We found the EGCrP2 homologue (Egh1; ORF name, Yir007w) in the genomic database of budding yeast S. cerevisiae, and, thus, characterized the enzyme in vivo as well as in vitro in the present study. We herein demonstrated that recombinant Egh1 (rEgh1) hydrolyzed various β-glucosides including SGs and the EGH1-disrupted mutants (egh1Δ) of S. cerevisiae accumulated EG in vivo, indicating that the enzyme is responsible for the catabolism of EG in S. cerevisiae. We also observed the fragmentation of vacuoles in egh1Δ, suggesting that a dysfunction in the catabolism of EG affected the process of vacuole fusion in S. cerevisiae.
Results

Molecular cloning and characterization of recombinant Egh1
We reported that an EGCase homologue of C. neoformans, EGCrP2, is an ergosteryl-β-glucosidase (Watanabe et al. 2015) . The EGCrP2 homologue is widely distributed in Ascomycetes, Basidiomycetes, Oomycetes and Zygomycetes (Supplementary data, Figure S1 ), while EGCrP1, which is a glucocerebrosidase, has been suggested be present in only Basidiomycetes and Zygomycetes. Egh1, an EGCrP2 homologue of S. cerevisiae, showed 34.2 and 18.5% identities, determined by the EMBOSS Needle (McWilliam et al. 2013) , with C. neoformans EGCrP2 and rhodococcal endoglycoceramidase (EGCase) II, respectively. The alignment of the deduced amino acid sequence of Egh1 with those of EGCrP2, EGCrP2 homologues and EGCase II revealed that eight amino acid residues, essential for the catalytic activity of glycoside hydrolase (GH) family 5 glycosidases (Sakon et al. 1996) , were completely conserved in these enzymes (Figure 1 , open and closed circles). Of the eight residues of Egh1, two catalytic glutamates, Glu265 and Glu515 were thought to be an acid-base catalyst and nucleophile, respectively ( Figure 1 , closed circles) (Ishibashi et al. 2012) .
To characterize the enzymatic properties of the Egh1, EGH1 gene encoding 764 residues was cloned from the cDNA of S. cerevisiae and expressed in E. coli BL21 (DE3) as a Trigger factor-fused protein. The rEgh1 was purified by a Nickel-conjugated Sepharose column, followed by gel filtration using a Superdex 200 column. The purified rEgh1 showed a protein band with a molecular mass of approximately 138 kDa on SDS-PAGE after staining with Coomassie Brilliant Blue ( Figure 2A, lane 3) . This molecular mass coincided with the deduced molecular mass of Trigger factor-conjugated Egh1.
Purified rEgh1 hydrolyzed EG, cholesteryl β-glucoside and sitosteryl β-glucoside to generate Glc ( Figure 2B ). The enzyme also hydrolyzed C6-7-nitro-2,1,3-benzoxadiazole (NBD)-GlcCer to generate C6-NBD-ceramide (Cer); however, it did not degrade any of the other NBD-glycosphingolipids (GSLs) tested or NBD-sphingomyelin (SM) ( Figure 2C ). rEgh1 hydrolyzed para-nitrophenyl ( pNP) β-Glc and 4-methylumbelliferyl (4MU) β-Glc ( Figure 2D ). These results clearly indicated that Egh1 was a β-glucosidase with broad aglycone specificity similar to EGCrP2. In contrast to EGCrP2, the EGCrP1 of C. neoformans was specific to GlcCer and was not able to hydrolyze any SGs including EG (Ishibashi et al. 2012; Watanabe et al. 2015 ). An EGCrP1 homologue was not found in the S. cerevisiae genome database, and this was consistent with S. cerevisiae not possessing GlcCer (Leipelt et al. 2001 ).
Identification of the glycolipid that accumulated in egh1Δ
To determine the physiological functions of Egh1, egh1Δ was generated from S. cerevisiae BY4741 (wild type, WT). β-Glucosidase activity was greatly reduced at acidic as well as neutral pH in egh1Δ when C6-NBD-GlcCer was used as a substrate ( Figure 3A) . The glycolipid, whose R f corresponded to that of sitosteryl β-glucoside, was detected in the total lipid fraction of egh1Δ, but not in that of WT ( Figure 3B , lanes 2 and 3). The glycolipid fraction was prepared from egh1Δ by a silica-based cartridge and subjected to reverse-phase high-performance liquid chromatography (HPLC) with diode-array detection. The UV spectra of the glycolipid eluted at 6.3 min ( peak indicated by the arrow, Figure 3C , upper panel) showed four absorbance peaks at 262, 271, 282 and 293 nm ( Figure 3C , lower panel), which are typical UV spectra for ergosterol (Naewbanij et al. 1984) . The main molecular ion peak, [M+NH 4 ] + , was observed at m/z 576 for the glycolipid with liquid chromatography-mass spectrometry (LC-MS), which is consistent with that of EG ( Figure 3D , upper panel). The MS/MS spectra of m/z 576 showed a predominant peak at m/z 379, which corresponds to an ergosterol ( Figure 3D , lower panel). MS/MS/MS analysis of the authentic EG confirmed that m/z 379 is from an ergosterol derived from EG (Supplementary data, Figure S2 ). Furthermore, the purified glycolipid was hydrolyzed by C. neoformans EGCrP2 to generate Glc and ergosterol, indicating that Glc was linked to ergosterol via the β-glycosidic linkage ( Figure 3E ). Collectively, these results clearly demonstrated that the glycolipid that accumulated in egh1Δ was EG, indicating that Egh1 was responsible for the degradation of EG in S. cerevisiae. EG was not detected in EGH1/UGT51-double knockout mutants (egh1Δugt51Δ) ( Figure 3B , lane 5), which indicated that EG was synthesized by Ugt51(Atg26) and degraded by Egh1 in vivo. The amount of EG accumulated in egh1Δ of S. cerevisiae was much lower than that in egcrp2Δ of C. neoformans ( Figure 3F ).
Intercellular localization of Egh1
To clarify the intracellular localization of Egh1, green fluorescence protein (GFP)-fused Egh1 was expressed in S. cerevisiae BY4741 (WT). In the present study, two types of Egh1 overexpressors driven with the TEF promoter were generated; one was fused with GFP at the carboxyl terminal of Egh1, while the other was fused at the aminoterminal of Egh1. Both GFP-fused Egh1 were detected as a 138-kDa band on western blotting using an anti-GFP antibody ( Figure 4A , lanes 2, 4). However, the expression of GFP-fused Egh1 was too low to detect under the conditions used whether GFP-fused protein was expressed with a natural EGH1 promoter ( Figure 4A , lane 3). We confirmed that the enzyme activities of the two Egh1 overexpressors were higher than that of WT, even though GFP was conjugated at either the amino-or carboxyl-terminal ( Figure 4B ). The intracellular distribution of two GFP-fused Egh1 differed depending on the site of GFP conjugated to Egh1, i.e., both were mainly localized at the cytosol, whereas one with the amino-terminal GFP (GFP N-OE) was also localized at an intracellular organelle with a granular structure ( Figure 4C ), suggesting that a putative targeting signal was located at the carboxyl terminal. As shown in Figure 4D , the intracellular localization of GFP N-OE was changed depending on the growth phase of S. cerevisiae, i.e., GFP N-OE was distributed in the cytosol until the initial logarithmic phase (12 h), then delivered to an organelle with a Fig. 1 . Alignment of Egh1 with EGCase II and fungal EGCrP2 homologues. The amino acid sequences of Rhodococcus EGCase II (accession: AAB67050.1), S. cerevisiae Egh1, C. neoformans EGCrP2 and EGCrP2 homologues from Rhizopus delemar (ORF Name: RO3G_04172), Schizophyllum commune (ORF Name: SCHCODRAFT_50957) and Aspergillus fumigatus (ORF Name: AFUA_3G08820) and Achlya hypogyna (accession number:AIG56220.1) were aligned using ClustalW (Thompson et al. 1994) and ESPript (Gouet et al. 2003) . White letters on a black background and black letters in an open box show identical and similar residues, respectively. Open circles indicate amino acid residues conserved in GH family 5 glycosidase. Two glutamates, the Glu270 and Glu520 of EGCrP2 and Glu265 and Glu515 of Egh1, are indicated by closed circles as a possible acid-base catalyst and nucleophile, respectively. + of EG (m/z 576). MS/MS was conducted using the peak at m/z 576 as a precursor ion. The arrow in lower panel indicated the ergosterol derived from EG at m/z 379. (E) The glycolipid eluted by HPLC at 5-10 min was pooled and digested by 1 μg of EGCrP2 (+) or heat-inactivated EGCrP2 (−) for 18 h at 30°C. Std, sitosteryl β-glucoside (upper) and Glc (lower) standards. (F) EG contents in S. cerevisiae (WT) and its EGH1-disrupted (egh1Δ) mutant (right), and C. neoformans and its EGCrP2-disrupted (egcrp2Δ) mutant (left). Lipids were extracted from 2.5 mg of dry cells and separated by HPLC equipped with a COSMOSIL 5C22-AR-II column. EG was quantified using a UV detector at 282 nm, which is characteristic UV absorbance for ergosterol ( Figure 3C ). Values represent the mean ± SD of three experiments. n.d., not detected. granule structure in the middle logarithmic phase (14 h), and finally localized at the vacuole membranes in the stationary phase (18-20 h) under the conditions applied. However, the organelle to which GFP N-OE was delivered at 14 h ( Figure 4D) has not yet been identified.
Effects of the disruption of EGH1 on vacuole morphology
We previously reported that the EGCrP2-disrupted mutants (egcrp2Δ) of C. neoformans showed distinct growth arrest, a dysfunction in cell budding, and an abnormal vacuole morphology (Watanabe et al. 2015) . However, no apparent difference was observed in cell growth and cell budding between WT and egh1Δ in under the conditions used.
On the other hand, a marked difference was detected in vacuole morphology. The egcrp2Δ of C. neoformans exhibited the hypertrophy of vacuoles, while the egh1Δ of S. cerevisiae showed the fragmentation of vacuoles when cells were observed under fluorescent microscopy after staining with 5-(and-6)-carboxy-2′,7′-dichlorofluorescein diacetate (carboxy-DCFDA) ( Figure 5A ). To quantify the fragmentation of vacuoles, cells were stained with N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl) pyridinium dibromide (FM4-64) ( Figure 5B ) and the number of vacuoles/cell was counted ( Figure 5C ). The results revealed that the number of cells exhibiting 1-2 vacuoles/cell decreased while those exhibiting 5-8 vacuoles/cell increased in egh1Δ ( Figure 5C ). Furthermore, the size of vacuoles decreased with the disruption of EGH1 ( Figure 5A and B). The abnormal vacuole morphology observed in egh1Δ ( Figure 5A -C) as well as Egh1 activity ( Figure 5D ) were restored by the expression of EGH1 in egh1Δ (revertants). Fragmentation of the vacuole was also observed in UGT51-disrupted and UGT51/EGH1-disrupted mutants (ugt51Δ and egh1Δ ugt51Δ) ( Figure 5A and B), suggesting that EG homeostasis is closely associated with the formation of vacuoles in S. cerevisiae. However, the phenotype of vacuole in ugt51Δ was less severe in compered with egh1Δ ( Figure 5C ).
Discussion
EGCase (EC 3.2.1.123; Cer glycanase) is an enzyme that is capable of hydrolyzing the O-glycosidic linkage between an oligosaccharide and Cer of various GSLs. However, EGCase hardly hydrolyzed GlcCer, and the minimum sugar structure required for the hydrolysis of GSLs is lactose Yamagata 1986, 1989) . EGCrP1 and EGCrP2 are homologues of EGCase; however, neither can hydrolyze GSLs, except for GlcCer, and, thus, the specificities of EGCrP1/ EGCrP2 are completely different from that of EGCase. EGCase is distributed from procaryotes to invertebrates, but not in yeasts, while EGCrP1/EGCrP2 are distributed in fungi and yeasts. EGCase is a glycohydrolase that belongs to GH family 5, which is one of the largest of all CAZy GH families and includes endoglucanase (cellulase), endomannanase, β-glucosidase and β-mannnosidase. EGCase was clarified the sole enzyme capable of hydrolyzing GSLs in GH family 5; however, EGCrP1/EGCrP2 emerged as other enzymes capable of hydrolyzing GSLs in GH family 5. The aglycone specificities of EGCase and EGCrP1 are strict (narrow) because they are specific to GSLs that are glycolipids containing a Cer (sphingoid bases). In contrast, the aglycone specificity of EGCrP2/Egh1 was shown to be very broad (Watanabe et al. 2015 ; this work), i.e., they were able to hydrolyze various β-glucosides, not only GlcCer but also various SGs and other artificial β-glucosides such as pNP β-Glc and 4MU β-Glc. It was important to determine how EGCrP2/Egh1 functioned in vivo, and we demonstrated that EG accumulated in the egcrp2Δ of C. neoformans (Watanabe et al. 2015 ) and egh1Δ of S. cerevisiae (this study), thereby indicating that EGCrP2/Egh1 physiologically functioned as an EG-degrading enzyme (ergosteryl-β-glucosidase), which is involved in the EG catabolic pathway in fungi and yeasts. EGCrP2 was distributed widely in fungi, which possess SGs including EG, and, thus, EGCrP2 may be a universal ergosteryl-β-glycosidase involved in the catabolism of SG in fungi (Watanabe et al. 2015) .
Fungal SGs are synthesized by Ugt51(Atg26) and this enzyme appears to be responsible for the synthesis of EG in S. cerevisiae (Warnecke et al. 1999 ). However, EG was undetectable not only in ugt51Δ but also in WT of S. cerevisiae; thus, it remains ambiguous whether Ugt51(Atg26) can synthesize EG in vivo of the budding yeast. The reason why EG was undetectable in S. cerevisiae regardless of the presence of Ugt51(Atg26) may have been due to the active catabolism of EG (Warnecke et al. 1999) , although the enzyme responsible for the degradation of EG had not been identified until this study. EG was detected in egh1Δ as expected ( Figure 3B ), indicating that EG was synthesized by Ugt51(Atg26) and degraded by Egh1 in vivo. It is worth nothing that the EG content in the WT of S. cerevisiae appears to be 20-fold less than that of C. neoformans when estimated by the HPLC-based assay ( Figure 3F ).
SG levels are known to increase in human fibroblasts with heat shock (Murakami-Murofushi et al. 1997; Kunimoto et al. 2000) . Since SG can induce the expression of HSP 70 in fibroblasts (Kunimoto et al. 2002) , it is considered to be an HSP inducible as well as stressinduced glycolipid in mammals. Heat shock also induced the accumulation of EG, a major SG in lower eukaryotes, in slime mold and fungi. However, the mechanism underlying the EG-mediated stress response may differ between mammals and lower eukaryotes because the enzymes responsible for the synthesis and degradation of SG (EG) are completely different, i.e., homologues of Ugt51(Atg26) and EGCrP2/ Egh1 have not been found in mammals; alternatively, the synthesis of SG appeared to be catalyzed by glucocerebrosidase GBA1, which transfers Glc from GlcCer to sterols (Akiyama et al. 2013 ). The enzyme responsible for the degradation of SG remains unknown in mammals.
The physiological significance of SGs remains to be elucidated; however, a study on the relationship between EG and pexophagy is of particular interest (Oku et al. 2003; Yamashita et al. 2006 ). Pexophagy, which is a kind of autophagy characterized by the degradation of peroxisomes in vacuoles, is frequently observed in the methylotrophic yeast P. pastoris, in which EG is a major glycolipid and inducible by heat shock (Sakaki et al. 2001) . The UGT51-disrupted mutant of P. pastoris, which lacks EG, lost the ability to undergo pexophagy, suggesting that EG and Ugt51 are involved in the process of pexophagy (Oku et al. 2003) . However, the lack of Ugt51(Atg26) did not affect the pexophagy in S. cerevisiae (Cao and Klionsky 2007) , and the reason was attributed to the low quantities of EG.
In the present study, we showed that the disruption of EGH1 resulted in vacuole fragmentation, as well as the accumulation of EG, in S. cerevisiae (Figure 3 ), and these phenotypes were restored by the expression of EGH1 in egh1Δ ( Figure 5 ). Interestingly, ugt51Δ also showed a similar phenotype to egh1Δ (Figure 5A-C) . These results indicate that EG homeostasis in S. cerevisiae is closely associated with the formation of vacuoles, because not only egh1Δ (lacking EG catabolism) but also ugt51Δ (lacking EG synthesis) showed similar vacuole phenotypes.
Several S. cerevisiae genes have been identified in relation to the formation of vacuoles, i.e., disruption of the genes responsible for the synthesis of ergosterol, phosphoinositide-3-phosphate, phosphoinositide-4,5-diphosphate, phosphatidic acid and phosphatidylethanolamine led to abnormal vacuole phenotypes (Mayer et al. 2000; Kato and Wickner 2001; Seeley et al. 2002; Mima et al. 2008) . The morphology of vacuoles in egh1Δ was similar to that in ergosterol-deficient mutants Ergosteryl-β-glucosidase in S. cerevisiae (C) Extent of fragmentation of vacuoles. The numbers of vacuoles/cell were counted using at least 100 cells after staining with FM4-64, and categorized into four groups: 1-2, 3-4, 5-8 and >9 vacuoles/cell. (D) β-Glucosidase activity of cell lysates as measured by C6-NBD-GlcCer as a substrate. WT and Rev represent wild type and revertant with EGH1, respectively. Activities were measured at 30°C for 18 h using 50 μg of cell lysate at pH 5.5. *P < 0.0001; ns, not significant. Error bars represent the mean ± SD of three experiments. (Kato and Wickner 2001) . One possible interpretation is that EG is a reservoir that provides ergosterol to the vacuoles in vivo.
Abnormal vacuole phenotypes were observed not only in egh1Δ but also in egcrp2Δ; however, these phenotypes appeared to be reversed, i.e., the former (exhibiting fragmented vacuoles) stemmed from a dysfunction in the fusion process, while the latter (exhibiting enlarged vacuoles), from a fission process during vacuole formation (Watanabe et al. 2015) . The reason for the discrepancy is currently ambiguous; however, variations in the quantity of EG in egcrp2Δ of C. neoformans and egh1Δ of S. cerevisiae cells ( Figure 3F ) may explain these different phenotypes.
The results obtained herein on Egh1 will shed light on the relationship between EG catabolism and vacuole formation in S. cerevisiae.
Materials and methods
Materials
EG was prepared from C. neoformans by the method previously described (Watanabe et al. 2015) . Cholesteryl β-glucoside and sitosteryl β-glucoside were purchased from Sigma-Aldrich and Matreya, respectively. C6-NBD-Cer, C6-NBD-GlcCer, C6-NBD-galactosylceramide (GalCer) and C12-NBD-globotriaosylceramide (Gb3Cer) were purchased from Matreya, and C6-NBD-lactosylceramide (LacCer), C12-NBD-SM and pNP glycosides were from Sigma-Aldrich. C12-NBD-Galβ1-3GalNAcβ1-4(NeuAcα2-3)Galβ1-4Glcβ1-1′Cer (GM1) and C12-NBD-NeuAcα2,3Galβ1Cer (GM4) were prepared using the sphingolipid Cer N-deacylase by a previously described method (Nakagawa et al. 1999) . Protease inhibitor cocktail (Complete mini EDTA-free) and anti-GFP antibody were purchased from Roche Diagnostics and MBL, respectively.
Generation of mutant strains
The mutant strains of S. cerevisiae used in the present study were prepared from the strain BY4741 (WT) and listed in Table I . The oligonucleotide primers used in this study are shown in Supplementary data, Table SI. Mutants were prepared by gene-specific disruption constructs generated by PCR using delYIR007W-S1 and delYIR007W-S2 primers, and pFA6a-kanMX4 (Janke et al. 2004 ) as a template for egh1Δ, and delUGT51-S1 and delUGT51-S2 primers for ugt51Δ, respectively. In order to generate egh1Δ ugt51Δ, hphMX4-S and hphMX4-A primers, and pFA6-hphNT1 (Janke et al. 2004 ) as a template were used to switch the selective marker of the gene replacement cassette in egh1Δ from kanMX4 to hphMX4, and UGT51 was disrupted by homologous recombination. Yeast cells, transformed by lithium acetate and heat shock methods, were cultured in YPD (2% Glc, 2% peptone, 1% yeast extract) medium with 200 mg/L of geneticin (G418) for kanMX4, 300 mg/L of hygromycin B for hphMX4 and 100 mg/L of nouseothricin (clonNAT) for natNT2, respectively. PCR was carried out using pRS416/yir007w-IF-S and pRS416/ yir007w-IF-A primers, and genomic DNA as a template, to generate revertants of EGH1 from egh1Δ. The amplified products were inserted into the EcoRI digestive pRS416 vector using the In-Fusion HD cloning kit (Takara Bio). Transformed yeast cells were cultured in SD medium (FORMEDIUM) lacking uracil.
GFP-fused Egh1 was created as described methods (Janke et al. 2004; Sheff and Thorn 2004) . Briefly, DNA fragments were generated by PCR using YIR007W-GFP127-S and YIR007W-GFP127-A primers, and pKT127 as a template for carboxy-terminal GFP-fused Egh1. To express amino-terminal GFP-fused Egh1 with TEF promoter, DNA fragments were amplified using delYIR007W-S1 and YIR007W-S4 primers, and pYM-N21 as a template. To exchange the natural EGH1 promoter with the TEF promoter, DNA fragments were amplified using the delYIR007W-S1 and YIR007W-S4 primers, and pYM-N19 as a template.
Construction of the expression vector
Total RNA was obtained from yeast cells using the SV Total RNA system (Promega). First-strand cDNA was synthesized from 1 μg of total RNA using the PrimeScript first-strand cDNA synthesis kit (Takara Bio). To insert the overlap region, PCR was carried out using firststrand cDNA as a template and the expression primers listed in Supplementary data, Table SI. The amplified product was inserted into the NdeI and PstI double digestive pCold TF (Takara Bio) vector using the In-Fusion HD cloning kit.
Expression and purification of recombinant Egh1
The S. cerevisiae EGH1 gene was expressed in Escherichia coli BL21 (DE3) using a pCold TF vector containing EGH1. After incubating transformants at 37°C in Luria-Bertani (LB) medium containing 100 μg/mL of ampicillin until the A 600 nm reached ∼0.6, the culture was kept at 15°C for 30 min. Isopropyl β-D-thiogalactopyranoside was then added to the culture at a final concentration of 1 mM. After being kept at 15°C for 24 h, the cells were harvested by centrifugation (8000 × g for 15 min), and suspended in 50 mM Tris-HCl buffer, pH 7.5, containing 150 mM NaCl and 20 mM imidazole. The suspension was kept in a sonic bath for 30 s; this procedure was repeated four times to crush the cells, and the cell debris was removed by centrifugation (18,000 × g for 15 min). The supernatant was applied to Ni Sepharose 6 Fast Flow resin (GE Healthcare) packed in Muromac mini column M (Muromachi Technos), and the column was then washed with 50 mM Tris-HCl, pH 7.5, containing 150 mM NaCl and 40 mM imidazole. rEgh1 was eluted with 50 mM Tris-HCl, pH 7.5, containing 150 mM NaCl and 200 mM imidazole. The purified enzyme was dialyzed against 50 mM TrisHCl, pH 7.5, containing 150 mM NaCl using Amicon Ultra-4 30k (Merck Millipore), and subjected to a Superdex 200 10/300 GL (GE Healthcare) gel filtration column equilibrated with 25 mM MES, pH 6.0, containing 100 mM NaCl. rEgh1 was eluted from the column with the same buffer at a flow rate of 0.5 mL/min, and each 0.5 mL fraction was collected using a fraction collector (GE Healthcare).
Protein assay
Protein content was determined by the Pierce 660 nm Protein Assay Reagent (Thermo Fisher Scientific) with bovine serum albumin as a This study
Ergosteryl-β-glucosidase in S. cerevisiae standard. SDS-PAGE was carried out according to the method of Laemmli (Laemmli 1970) with the Spectra Multicolor Broad Range Protein Ladder (Thermo Fisher Scientific) as a molecular weight marker. Proteins were stained with CBB Stain One (Nacalai Tesque).
Enzyme assay
An aliquot of each substrate (NBD-labeled GSLs, pNP glycosides, cholesteryl β-glucoside and sitosteryl β-glucoside) was incubated at 30°C for an appropriate period with the enzyme in 20 μL of 50 mM phosphate buffer, pH 5.5, containing 0.025% sodium cholate. The reaction mixture, dried using a SpeedVac concentrator, was dissolved in 10 μL of chloroform-methanol (1 : 2, v/v) and applied to a Silica Gel 60 TLC plate (Merck Millipore), which was developed with chloroform/methanol/water (60 : 35 : 8, 65 : 25 : 4 or 65 : 16 : 2, v/v/ v) . NBD-labeled GSLs were visualized using AE-6935B VISIRAYS-B (ATTO). The C6-NBD-Cer generated by the enzyme reaction was separated from C6-NBD-GlcCer on a normal phase HPLC column (Inertsil SIL 150A-5, GL Sciences) and quantified according to the method described by Hayashi et al. (2008) . EG, cholesteryl β-glucoside, sitosteryl β-glucoside and Glc were visualized by spraying the TLC plate with Orcinol sulfate reagent. p-Nitrophenol released from pNP glycosides by the action of the enzyme was measured at 405 nm with a Multiskan FC microplate reader (Thermo Fisher Scientific).
Crude enzyme preparation
Yeasts were grown in YPD medium at 30°C, harvested at A 600 nm 0.8-1.0 by centrifugation (4400 × g for 2 min at 4°C), and washed twice with PBS. Ten microliters of the cell suspension (A 600 nm 1.0) were added to lysis buffer (50 mM phosphate buffer, pH 7.3, containing protease inhibitor) and crushed at 3200 rpm for 30 s on ice with a bead crusher μT-12 (TAITEC) using ∼0.2 cm 3 of 0.6-mm diameter glass beads in a 1.5-mL tube. This procedure was repeated three times. The supernatant was obtained by centrifugation at 800 × g for 15 min at 4°C.
Extraction and purification of glycolipids
Total lipids were extracted from S. cerevisiae with chloroform/methanol (1 : 2, v/v), and applied to a TLC plate (corresponding to 30 mg dry cells per lane), which was developed with chloroform/methanol/ water (65 : 16 : 2, v/v/v) as a developing solvent, and stained with Orcinol sulfate reagent. The glycolipid that accumulated in egh1Δ was extracted with chloroform/methanol (1 : 2, v/v) and treated with 0.1 M NaOH. Alkaline-resistant lipids were dissolved in chloroform and loaded onto a Sep-Pak plus silica column cartridge equilibrated with chloroform. The lipids were eluted from the cartridge by a stepwise elution with chloroform, chloroform/methanol (98 : 2, v/v), chloroform/methanol (95 : 5, v/v) and chloroform/methanol (90 : 10, v/v). The glycolipid was mainly recovered in the chloroform/methanol (95 : 5, v/v) fraction.
HPLC and MS analyses
A reverse-phase HPLC analysis was conducted using a LaChrom Elite HPLC system (Hitachi) with a diode-array UV-visible detector and COSMOSIL 5C22-AR-II column (4.6 × 250 mm, 5 μm, Nacalai Tesque) using methanol as an isocratic mobile phase, which was operated at a flow rate of 1 mL/min at 40°C in a column oven. LC-MS was performed using an HPLC system (Agilent Technologies) coupled to a mass spectrometry apparatus (3200 QTRAP/MS/MS, AB SCIEX). LC was conducted using an Inertsustain C18 column (2.1 × 150 mm, 5 μm, GL Sciences) with methanol/1 M ammonium formate (99 : 1, v/v) as the eluent at a flow rate of 200 μL/min at 40°C in a column oven. An MS analysis was performed under the following conditions: ion spray voltage, 5500 V; declustering potential, 51 V; collision energy, 30 eV; resolution of Q1/Q3, unit.
Vacuole staining
Vacuoles were observed under fluorescent microscopy after the incorporation of carboxy-DCFDA (Molecular Probes) or FM4-64 (Molecular Probes). To verify vacuole formation, the number of vacuoles per 100 cells was counted according to the method described by Baars et al. (2007) . At least three independent experiments were carried out, and categorized into four groups: 1-2, 3-4, 5-8 and >9 vacuoles/cell. Cells were cultured overnight at 25°C in YPD (WT, egh1Δ, ugt51Δ; lane 5, ugt51Δ egh1Δ) or SD (Rev) medium, transferred into fresh YPD medium, and then grown at 25°C for 1.5-day.
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